Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic
Open Access
- 2 March 2021
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 325 (9), 825-826
- https://doi.org/10.1001/jama.2020.25384
Abstract
This Viewpoint considers whether the shift away from private investment toward government funding of drug and vaccine development and commercialization during tThis publication has 4 references indexed in Scilit:
- Drug Reimbursement Regulation in 6 Peer CountriesJAMA Internal Medicine, 2020
- Are Regulation and Innovation Priorities Serving Public Health Needs?Frontiers in Pharmacology, 2019
- Addressing Antimicrobial Resistance and StewardshipJAMA, 2017
- Cardiovascular Drug DevelopmentJournal of Invasive Cardiology, 2015